| Complexity, reductionism and the biomedical model E Rocca, RL Anjum Rethinking causality, complexity and evidence for the unique patient: A …, 2020 | 147 | 2020 |
| Rethinking causality, complexity and evidence for the unique patient: a causehealth resource for healthcare professionals and the clinical encounter RL Anjum, S Copeland, E Rocca Springer Nature, 2020 | 93 | 2020 |
| Philosophical bias is the one bias that science cannot avoid F Andersen, RL Anjum, E Rocca Elife 8, e44929, 2019 | 80 | 2019 |
| Medical scientists and philosophers worldwide appeal to EBM to expand the notion of ‘evidence’ RL Anjum, S Copeland, E Rocca BMJ evidence-based medicine 25 (1), 6-8, 2020 | 60 | 2020 |
| TSHZ1-dependent gene regulation is essential for olfactory bulb development and olfaction D Ragancokova, E Rocca, AMM Oonk, H Schulz, E Rohde, J Bednarsch, ... The Journal of clinical investigation 124 (3), 1-14, 2022 | 51 | 2022 |
| Pharmacovigilance as scientific discovery: an argument for trans-disciplinarity E Rocca, S Copeland, I Ralph Edwards Drug safety 42 (10), 1115-1124, 2019 | 40 | 2019 |
| Causal evidence and dispositions in medicine and public health E Rocca, RL Anjum International Journal of Environmental Research and Public Health 17 (6), 1813, 2020 | 30 | 2020 |
| Humoral and cellular immune responses in mice after airway administration of Bacillus thuringiensis Cry1Ab and MON810 cry1Ab-transgenic maize M Andreassen, E Rocca, T Bøhn, OG Wikmark, J van den Berg, M Løvik, ... Food and Agricultural Immunology 26 (4), 521-537, 2015 | 30 | 2015 |
| Bridging the boundaries between scientists and clinicians—mechanistic hypotheses and patient stories in risk assessment of drugs E Rocca Journal of Evaluation in Clinical Practice 23 (1), 114-120, 2017 | 25 | 2017 |
| How biological background assumptions influence scientific risk evaluation of stacked genetically modified plants: an analysis of research hypotheses and argumentations E Rocca, F Andersen Life sciences, society and policy 13, 1-20, 2017 | 22 | 2017 |
| Causal insights from failure: Post-marketing risk assessment of drugs as a way to uncover causal mechanisms E Rocca, RL Anjum, S Mumford Uncertainty in pharmacology: Epistemology, methods, and decisions, 39-57, 2020 | 20 | 2020 |
| The judgements that evidence‐based medicine adopts E Rocca Journal of Evaluation in Clinical Practice 24 (5), 1184-1190, 2018 | 20 | 2018 |
| From ideal to real risk: philosophy of causation meets risk analysis RL Anjum, E Rocca Risk Analysis 39 (3), 729-740, 2019 | 19 | 2019 |
| CauseHealth: integrating philosophical perspectives into person centered healthcare R Anjum, S Copeland, S Mumford, E Rocca European Journal for Person Centered Healthcare 3 (4), 427-430, 2015 | 16 | 2015 |
| Remdesivir in the COVID-19 pandemic: an analysis of spontaneous reports in VigiBase during 2020 E Rocca, O Gauffin, R Savage, SH Vidlin, B Grundmark Drug Safety 44 (9), 987-998, 2021 | 13 | 2021 |
| Rethinking causality, complexity and evidence for the unique patient: A causehealth resource for healthcare professionals and the clinical encounter E Rocca Springer, 2020 | 11 | 2020 |
| Introduction: Why is philosophy relevant for clinical practice? RL Anjum, S Copeland, E Rocca Rethinking Causality, Complexity and Evidence for the Unique Patient: A …, 2020 | 11 | 2020 |
| The guidelines challenge—Philosophy, practice, policy. RL Anjum, S Copeland, R Kerry, E Rocca Journal of Evaluation in Clinical Practice 24 (5), 2018 | 10 | 2018 |
| Underdetermination and evidence-based policy F Andersen, E Rocca Studies in History and Philosophy of Science Part C: Studies in History and …, 2020 | 9 | 2020 |
| Evidence of biological mechanisms and health predictions: an insight into clinical reasoning S Pérez-González, E Rocca Perspectives in Biology and Medicine 65 (1), 89-105, 2022 | 8 | 2022 |
Samantha CopelandTU DelftVerified email at tudelft.nl
